Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 9;24(1):179.
doi: 10.1186/s12879-024-09055-z.

Creation of a pandemic memory by tracing COVID-19 infections and immunity in Luxembourg (CON-VINCE)

Olena Tsurkalenko #  1 , Dmitry Bulaev #  2 , Marc Paul O'Sullivan  2 , Chantal Snoeck  2 , Soumyabrata Ghosh  3 , Alexey Kolodkin  2 , Basile Rommes  3 , Piotr Gawron  3 , Armin Rauschenberger  2   3 , Carlos Vega Moreno  3 , Clarissa P C Gomes  3 , Anne Kaysen  3 , Jochen Ohnmacht  2 , Valerie E Schröder  3   4 , Lukas Pavelka  2   4 , Guilherme Ramos Meyers  2   3 , Laure Pauly  2 , Claire Pauly  2   4 , Anne-Marie Hanff  2   3   5 , Max Meyrath  2 , Anja Leist  3 , Estelle Sandt  2 , Gloria A Aguayo  2 , Magali Perquin  2 , Manon Gantenbein  2 , Tamir Abdelrahman  6 , Jochen Klucken  2   3 , Venkata Satagopam  3 , Christiane Hilger  2 , Jonathan Turner  2 , Michel Vaillant  2 , Joëlle V Fritz  2 , Markus Ollert  2 , Rejko Krüger  2   3   4 ; CON-VINCE consortium and the ORCHESTRA working group
Collaborators, Affiliations

Creation of a pandemic memory by tracing COVID-19 infections and immunity in Luxembourg (CON-VINCE)

Olena Tsurkalenko et al. BMC Infect Dis. .

Erratum in

  • Correction: Creation of a pandemic memory by tracing COVID-19 infections and immunity in Luxembourg (CON-VINCE).
    Tsurkalenko O, Bulaev D, O'Sullivan MP, Snoeck C, Ghosh S, Kolodkin A, Rommes B, Gawron P, Moreno CV, Gomes CPC, Kaysen A, Ohnmacht J, Schröder VE, Pavelka L, Meyers GR, Pauly L, Pauly C, Hanff AM, Meyrath M, Leist A, Sandt E, Aguayo GA, Perquin M, Gantenbein M, Abdelrahman T, Klucken J, Satagopam V, Hilger C, Turner J, Vaillant M, Fritz JV, Ollert M, Krüger R; CON-VINCE consortium and the ORCHESTRA working group. Tsurkalenko O, et al. BMC Infect Dis. 2025 Jul 3;25(1):892. doi: 10.1186/s12879-025-11160-6. BMC Infect Dis. 2025. PMID: 40610940 Free PMC article. No abstract available.

Abstract

Background: During the COVID-19 pandemic swift implementation of research cohorts was key. While many studies focused exclusively on infected individuals, population based cohorts are essential for the follow-up of SARS-CoV-2 impact on public health. Here we present the CON-VINCE cohort, estimate the point and period prevalence of the SARS-CoV-2 infection, reflect on the spread within the Luxembourgish population, examine immune responses to SARS-CoV-2 infection and vaccination, and ascertain the impact of the pandemic on population psychological wellbeing at a nationwide level.

Methods: A representative sample of the adult Luxembourgish population was enrolled. The cohort was followed-up for twelve months. SARS-CoV-2 RT-qPCR and serology were conducted at each sampling visit. The surveys included detailed epidemiological, clinical, socio-economic, and psychological data.

Results: One thousand eight hundred sixty-five individuals were followed over seven visits (April 2020-June 2021) with the final weighted period prevalence of SARS-CoV-2 infection of 15%. The participants had similar risks of being infected regardless of their gender, age, employment status and education level. Vaccination increased the chances of IgG-S positivity in infected individuals. Depression, anxiety, loneliness and stress levels increased at a point of study when there were strict containment measures, returning to baseline afterwards.

Conclusion: The data collected in CON-VINCE study allowed obtaining insights into the infection spread in Luxembourg, immunity build-up and the impact of the pandemic on psychological wellbeing of the population. Moreover, the study holds great translational potential, as samples stored at the biobank, together with self-reported questionnaire information, can be exploited in further research.

Trial registration: Trial registration number: NCT04379297, 10 April 2020.

Keywords: Coronavirus (COVID-19); Prevalence; Prospective cohort study; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Data management
Fig. 2
Fig. 2
Flowchart describing each visit of the study
See this image and copyright information in PMC

References

    1. Wikipedia. COVID-19 pandemic in Luxembourg. 2020 Available from: https://en.wikipedia.org/wiki/COVID-19_pandemic_in_Luxembourg#cite_note-8.[cited 2023].
    1. Radon K, et al. Protocol of a population-based prospective COVID-19 cohort study Munich, Germany (KoCo19). BMC Public Health. 2020;20(1):1036. - PMC - PubMed
    1. Nyberg F, et al. Swedish Covid-19 Investigation for Future Insights - A Population Epidemiology Approach Using Register Linkage (SCIFI-PEARL). Clin Epidemiol. 2021;13:649–59. - PMC - PubMed
    1. Espenhain L, et al. Prevalence of SARS-CoV-2 antibodies in Denmark: nationwide, population-based seroepidemiological study. Eur J Epidemiol. 2021;36(7):715–25. - PMC - PubMed
    1. Wu HH, et al. Healthcare-associated COVID-19 outbreaks: a nationwide population-based cohort study. J Hosp Infect. 2022;124:29–36. - PMC - PubMed

Associated data